~~<i id='38F3C5A14E'><strike id='38F3C5A14E'><tt id='38F3C5A14E'><pre id='38F3C5A14E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：knowledge 2025-09-29 20:51:42 - browse：8

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： CDC Director Mandy Cohen on transparency, trust, and health

entertainment

focus

explore

knowledge

hotspot

knowledge

Reps.RichardNeal(D-Mass.),Rep.FrankPallone(D-N.J.),andRep.JohnYarmuth(D-Ky.)JoeRaedle/GettyImagesWAS

WSS

MultiPlan and major insurers sued for alleged medical price

MassMutual is introducing free genetic testing for members

Roche’s Alnylam deal shows drug firms interested in heart drugs

Dems pitch expanding Medicare power to negotiate drug prices

Cancer researcher Catriona Jamieson is sending tumors into space

New lawsuit accuses health insurer Cigna of denying claims in bulk

focus

fashion

entertainment

Activists slam private health insurers over coverage restrictions

Key Senate committee drafts bipartisan bill to stem drug shortages

As demand for Covid shots wanes, Moderna seeks its next success

What causes rare myocarditis in young men after Covid vaccines?

Supreme Court strikes down use of affirmative action

Orangutan used medicinal plant to treat wound, first time ever seen

In age of alternative facts, a scholarly course on calling out crap

Former reverend arrested for allegedly killing 8

The cancer drug shortage isn’t new — and neither are the solutions

The battle over 'scope creep' and who gets to be called 'doctor'

focus

Getting Alzheimer's drug Leqembi to patients can be a challenge

STAT Report: Patient voices and perspectives

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Why does health care cost so much? A reading guide

Cholera vaccine supply gets boost as demand surges globally

Cholera vaccine supply gets boost as demand surges globally

explore

knowledge

hotspot

knowledge